Journal of the American Heart Association · 2025
Prognostic Impact of Infarct Size and Coronary Microvascular Function Via Cardiovascular Magnetic Resonance and Coronary Angiography-Derived Index of Microcirculatory Resistance in Myocardial Infarction With Nonobstructive Coronary Arteries.
СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abdu Fuad A, Chen Lei, Qiu Bowen, Liu Lu, Mohammed Abdul-Quddus, Lv Xian, Yin Guoqing, Zhang Wen, Alifu Jiasuer, Chen Wensu, Lu Yuan, Che Wenliang
Аннотация
BACKGROUND: Infarct size (IS) and microvascular obstruction (MVO), measured by cardiovascular magnetic resonance, are key prognostic markers after myocardial infarction (MI). The index of microcirculatory resistance (IMR) predicts MVO and IS; however, its role in MI with nonobstructive coronary arteries (MINOCA) is unclear. This study explored the relationship between coronary angiography-derived IMR, MVO, and IS in true MINOCA and assessed the prognostic value of coronary microvascular dysfunction (CMD), IS, and MVO.
METHODS: Patients with suspected MINOCA who completed cardiovascular magnetic resonance and coronary angiography-derived IMR were included. CMD was defined as coronary angiography-derived IMR >25, and IS as a percentage of left ventricular mass (IS%LV) measured by late gadolinium enhancement. True MINOCA was identified by cardiovascular magnetic resonance evidence of ischemia or infarction. Individuals with true MINOCA were divided into 3 groups: non-CMD and IS%LV <16.78%, CMD or IS%LV ≥16.78%, and CMD with IS%LV ≥16.78%. Follow-up for major adverse cardiovascular events was conducted.
RESULTS: Of 317 patients, 102 had true MINOCA (91.2% non-ST-segment-elevation MI). CMD was similarly distributed across all suspected MINOCA. Coronary angiography-derived IMR did not predict MVO or IS among true MINOCA. Over a median 27 months, 33.3% of patients with true MINOCA experienced major adverse cardiovascular events, with a higher risk in patients with CMD or IS%LV ≥16.78%. Multivariate Cox analysis revealed that CMD combined with IS%LV ≥16.78% had a hazard ratio (HR) of 7.40 (95% CI, 1.94-28.23), and either CMD or IS%LV ≥16.78% had an HR of 8.77 (95% CI, 2.57-29.94), but MVO did not. Sensitivity analyses excluding ST-segment-elevation MI supported these findings.
CONCLUSIONS: CMD with larger IS strongly predicts major adverse cardiovascular events in MINOCA, underscoring their utility in risk stratification, especially for non-ST-segment-elevation MI.
REGISTRATION: URL: https://clinicaltrials.gov. Unique identifier: NCT06502899.
METHODS: Patients with suspected MINOCA who completed cardiovascular magnetic resonance and coronary angiography-derived IMR were included. CMD was defined as coronary angiography-derived IMR >25, and IS as a percentage of left ventricular mass (IS%LV) measured by late gadolinium enhancement. True MINOCA was identified by cardiovascular magnetic resonance evidence of ischemia or infarction. Individuals with true MINOCA were divided into 3 groups: non-CMD and IS%LV <16.78%, CMD or IS%LV ≥16.78%, and CMD with IS%LV ≥16.78%. Follow-up for major adverse cardiovascular events was conducted.
RESULTS: Of 317 patients, 102 had true MINOCA (91.2% non-ST-segment-elevation MI). CMD was similarly distributed across all suspected MINOCA. Coronary angiography-derived IMR did not predict MVO or IS among true MINOCA. Over a median 27 months, 33.3% of patients with true MINOCA experienced major adverse cardiovascular events, with a higher risk in patients with CMD or IS%LV ≥16.78%. Multivariate Cox analysis revealed that CMD combined with IS%LV ≥16.78% had a hazard ratio (HR) of 7.40 (95% CI, 1.94-28.23), and either CMD or IS%LV ≥16.78% had an HR of 8.77 (95% CI, 2.57-29.94), but MVO did not. Sensitivity analyses excluding ST-segment-elevation MI supported these findings.
CONCLUSIONS: CMD with larger IS strongly predicts major adverse cardiovascular events in MINOCA, underscoring their utility in risk stratification, especially for non-ST-segment-elevation MI.
REGISTRATION: URL: https://clinicaltrials.gov. Unique identifier: NCT06502899.